Skip to main content
. Author manuscript; available in PMC: 2015 Jun 25.
Published in final edited form as: N Engl J Med. 2009 Sep 24;361(13):1249–1259. doi: 10.1056/NEJMoa0904544

Figure 3. Kaplan–Meier Estimates of Overall Survival, According to Mutation Status.

Figure 3

Data are shown for the overall survival of patients with the FLT3-ITD mutation (Panel A), those without the FLT3-ITD mutation (Panel B), those with the MLL-PTD mutation (Panel C), and those without the MLL-PTD mutation (Panel D). Also shown are survival curves for patients who received high-dose daunorubicin (90 mg per square meter of body-surface area per day), according to the presence or absence of the FLT3-ITD genotype (Panel E). ITD denotes internal tandem duplication, and PTD partial tandem duplication.